Control Bionics Limited (CBL.AX)
AUD 0.04
(-5.13%)
AUD 0.04
(-5.13%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 9.02 Million AUD | 3.81% |
| 2023 | 8.69 Million AUD | -35.28% |
| 2022 | 13.43 Million AUD | -26.79% |
| 2021 | 18.35 Million AUD | -10.53% |
| 2020 | 20.51 Million AUD | 277.82% |
| 2019 | 5.42 Million AUD | -13.91% |
| 2018 | 6.3 Million AUD | -99.48% |
| 2017 | 1.2 Billion NZD | 61.83% |
| 2016 | 743.95 Million NZD | 19.47% |
| 2015 | 622.7 Million NZD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 9.02 Million AUD | 1.14% |
| 2024 Q2 | 8.92 Million AUD | 0.0% |
| 2024 Q4 | 9.02 Million AUD | 0.0% |
| 2024 FY | 9.02 Million AUD | 3.81% |
| 2024 Q1 | 8.92 Million AUD | 2.64% |
| 2023 Q2 | 11.04 Million AUD | 0.0% |
| 2023 Q4 | 8.69 Million AUD | 0.0% |
| 2023 FY | 8.69 Million AUD | -35.28% |
| 2023 Q3 | 8.69 Million AUD | -21.26% |
| 2023 Q1 | 11.04 Million AUD | -17.8% |
| 2022 FY | 13.43 Million AUD | -26.79% |
| 2022 Q4 | 13.43 Million AUD | 0.0% |
| 2022 Q3 | 13.43 Million AUD | -18.51% |
| 2022 Q2 | 16.48 Million AUD | 0.0% |
| 2022 Q1 | 16.48 Million AUD | -10.16% |
| 2021 Q1 | - AUD | -100.0% |
| 2021 FY | 18.35 Million AUD | -10.53% |
| 2021 Q4 | 18.35 Million AUD | 0.0% |
| 2021 Q3 | 18.35 Million AUD | -10.12% |
| 2021 Q2 | 20.42 Million AUD | 0.0% |
| 2020 Q4 | 6.34 Million AUD | 0.0% |
| 2020 FY | 20.51 Million AUD | 277.82% |
| 2019 FY | 5.42 Million AUD | -13.91% |
| 2018 FY | 6.3 Million AUD | -99.48% |
| 2017 FY | 1.2 Billion NZD | 61.83% |
| 2017 Q2 | 1.2 Billion NZD | 0.0% |
| 2016 FY | 743.95 Million NZD | 19.47% |
| 2015 FY | 622.7 Million NZD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| 4DMedical Limited | 120.01 Million AUD | 92.478% |
| Adherium Limited | 9.88 Million AUD | 8.697% |
| Aroa Biosurgery Limited | 101.82 Million AUD | 91.134% |
| Atomo Diagnostics Limited | 11.37 Million AUD | 20.667% |
| Anteris Technologies Ltd | 45.7 Million AUD | 80.247% |
| CardieX Limited | 12.64 Million AUD | 28.637% |
| Compumedics Limited | 40.35 Million AUD | 77.632% |
| Cochlear Limited | 2.74 Billion AUD | 99.671% |
| CleanSpace Holdings Limited | 26.05 Million AUD | 65.349% |
| Cyclopharm Limited | 45.91 Million AUD | 80.339% |
| EMVision Medical Devices Ltd | 23.97 Million AUD | 62.341% |
| Nova Eye Medical Limited | 29.88 Million AUD | 69.79% |
| HeraMED Limited | 2.95 Million AUD | -205.794% |
| Imricor Medical Systems, Inc. | 12.17 Million AUD | 25.86% |
| ImpediMed Limited | 46.98 Million AUD | 80.787% |
| InhaleRx Limited | 1.57 Million AUD | -472.478% |
| LBT Innovations Limited | 7.93 Million AUD | -13.823% |
| Micro-X Limited | 26.89 Million AUD | 66.435% |
| Neurotech International Limited | 12.21 Million AUD | 26.087% |
| OncoSil Medical Limited | 6.71 Million AUD | -34.367% |
| PolyNovo Limited | 109.16 Million AUD | 91.731% |
| Respiri Limited | 6.19 Million AUD | -45.815% |
| SomnoMed Limited | 69.8 Million AUD | 87.068% |
| Universal Biosensors, Inc. | 30.12 Million AUD | 70.029% |
| Uscom Limited | 5.13 Million AUD | -75.812% |
| Visioneering Technologies, Inc. | 11.2 Million AUD | 19.438% |